Healthcare
THC Therapeutics, Inc.(THCT)
Live Price
Offline$0.003
+0.00% today
1Y Change
+2900.00%
Window
Jun 23, 2025 → Jun 12, 2026
- Market Cap
- —
- Revenue Growth
- 0.0%
- EPS Growth
- +74.2%
- Dividend Yield
- 0.0%
Coverage: 240 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
THC Therapeutics, Inc. (THCT) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 2900.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +74.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +74.2%, free cash flow +79.6% with operating margin 0.0% and ROIC 20.4%. Stock Foundry combines THCT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +74.2%, while operating margin sits near 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THCT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THCT Max Drawdown
-99.47%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for THCT and SPY.
Company Overview
THC Therapeutics, Inc.
Other OTC
THC Therapeutics, Inc. operates in the wellness industry. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada.
- Leadership
- Scott A. Cox
- IPO Date
- Jan 23, 2017
- Employees
- 1
- Street Address
- 11700 W Charleston Boulevard
- Mailing
- Las Vegas, NV, 89135
- Region
- Las Vegas, NV, US
- Reporting Currency
- USD
- Investor Line
- 833 420 8428
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- —
- Price/Book
- —
Growth
- Revenue
- 0.0%
- EPS
- +74.2%
- Free Cash Flow
- +79.6%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 12.1%
- ROIC
- 20.4%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.